V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214416 | 20129872 | 1.66 | 66 | Adjuvant (A) | 2017-12-24 | 2017-12-24 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100137742 |
| 20214418 | 20129873 | 1.84 | 58.8 | Neo-adjuvant (N) | 2016-04-01 | 2016-04-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100467468 |
| 20214420 | 20129874 | 1.72 | 69.55 | Adjuvant (A) | 2018-01-19 | 2018-03-07 | EOX | 2 | N | EOX | 100626429 |
| 20214421 | 20129875 | 1.7 | 53 | Neo-adjuvant (N) | 2019-04-07 | 2019-04-18 | Trial Unspecified | 2 | Y | TRIAL | 101287588 |
| 20214422 | 20129876 | 1.72 | 129.2 | null | 2018-07-26 | 2018-07-27 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 100625155 |
| 20214423 | 20129877 | 1.79 | 57.5 | Palliative (P) | null | 2019-07-12 | Cetuximab + Oxaliplatin + MdG Maint | Y | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100141526 |
| 20214424 | 20129878 | 1.74 | 90.7 | Palliative (P) | 2016-08-07 | 2016-08-14 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101717630 |
| 20214426 | 20129879 | 1.72 | 50.3 | Adjuvant (A) | 2018-02-19 | 2018-02-23 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100070454 |
| 20214429 | 20129880 | 1.58 | 0 | Palliative (P) | 2019-08-12 | 2019-08-26 | EOX | 2 | N | OXALIPLATIN + RALTITREXED | 101298321 |
| 20214430 | 20129881 | 1.45 | 73.5 | Adjuvant (A) | 2019-04-14 | 2019-04-24 | Oxaliplatin + Raltitrexed | 2 | N | OXALIPLATIN + RALTITREXED | 100601054 |
| 20214432 | 20129882 | 1.52 | 60 | Palliative (P) | 2019-03-11 | 2019-03-11 | CETUXIMAB + IRINOTECAN + MDG | N | Y | CETUXIMAB + IRINOTECAN + MDG | 101203115 |
| 20214433 | 20129883 | 1.87 | 113.2 | Neo-adjuvant (N) | 2018-10-25 | 2018-10-25 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100597073 |
| 20214435 | 20129884 | 1.6 | 77 | Palliative (P) | 2019-08-11 | 2019-08-26 | EOX | N | Y | EOX | 101045950 |
| 20214436 | 20129885 | 1.84 | 69.6 | Palliative (P) | 2018-02-19 | 2018-02-19 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100876801 |
| 20214439 | 20129886 | 1.7 | 89.3 | Adjuvant (A) | 2020-03-30 | 2020-04-09 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100433844 |
| 20214440 | 20129887 | 1.85 | 98.3 | Palliative (P) | 2016-03-14 | 2016-10-31 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100665461 |
| 20214442 | 20129888 | 1.82 | 82.5 | Palliative (P) | 2017-01-28 | 2017-08-12 | Capecitabine 35days + RT | 99 | N | OXALIPLATIN + RALTITREXED | 100736970 |
| 20214443 | 20129889 | null | 72.3 | Palliative (P) | 2017-01-14 | 2017-01-21 | Sorafenib | N | N | SORAFENIB | 100618953 |
| 20214444 | 20129890 | 1.72 | 74 | Palliative (P) | 2019-07-01 | 2019-08-03 | EOX | N | N | EOX | 101198319 |
| 20214446 | 20129891 | 1.62 | 51 | Palliative (P) | 2021-02-25 | 2021-02-25 | EOX | 2 | Y | EOX | 100745124 |
| 20214448 | 20129892 | 1.67 | 61.8 | null | 2017-10-27 | 2018-01-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101827056 |
| 20214452 | 20129893 | 1.72 | 92.5 | Palliative (P) | 2019-06-24 | 2019-07-22 | EOX | 02 | Y | EOX | 101793752 |
| 20214458 | 20129894 | 1.75 | 85.3 | Adjuvant (A) | 2020-01-11 | 2020-01-11 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100411350 |
| 20214459 | 20129895 | 0 | 97 | Palliative (P) | 2019-11-04 | 2019-11-12 | EOX | N | N | EOX | 101165834 |
| 20214461 | 20129896 | 1.5 | null | Palliative (P) | 2013-03-30 | 2013-05-31 | EOX | 02 | N | EOX | 101848460 |
| 20214464 | 20129897 | 1.67 | 71.1 | Palliative (P) | 2020-02-25 | 2020-02-25 | Trial Unspecified | 02 | null | TRIAL | 100150054 |
| 20214466 | 20129898 | 1.83 | 87.8 | Palliative (P) | 2019-07-27 | 2019-08-03 | EOX | 02 | N | SORAFENIB | 100100404 |
| 20214467 | 20129899 | 1.7 | 59.1 | Adjuvant (A) | 2019-08-30 | 2019-12-07 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + IRINOTECAN + MDG | 101569839 |
| 20214468 | 20129900 | 1.58 | 83.1 | Palliative (P) | 2019-07-22 | 2020-08-09 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101508873 |
| 20214471 | 20129901 | 1.6 | 51 | Curative (C) | 2018-11-27 | 2018-12-29 | EOX | Y | N | TRIAL | 100243089 |
| 20214472 | 20129902 | 1.75 | 72 | Adjuvant (A) | 2016-07-31 | 2016-07-31 | Trial Unspecified | N | N | TRIAL | 101407659 |
| 20214473 | 20129903 | 1.75 | 74.2 | Palliative (P) | 2018-08-17 | 2018-08-22 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101300224 |
| 20214474 | 20129904 | 1.79 | 69 | Palliative (P) | 2019-08-04 | 2019-08-05 | EOX | 02 | N | EOX | 101612884 |
| 20214475 | 20129905 | 1.6 | 62.9 | Palliative (P) | 2018-05-01 | 2018-05-04 | Capecitabine 35days + RT | N | N | CETUXIMAB + IRINOTECAN + MDG | 101343985 |
| 20214479 | 20129906 | 1.91 | 85 | Adjuvant (A) | 2016-06-02 | 2016-11-12 | EOX | N | N | EOX | 101079619 |
| 20214480 | 20129907 | 1.6 | 75.9 | Neo-adjuvant (N) | 2016-10-14 | 2016-10-25 | Capecitabine 5days + RT | 02 | N | CAPECITABINE + RT | 100545463 |
| 20214482 | 20129908 | 1.69 | 97.4 | Palliative (P) | 2018-10-18 | 2018-10-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101074940 |
| 20214484 | 20129909 | 1.6 | 71.2 | Adjuvant (A) | 2018-02-10 | 2018-02-24 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100126593 |
| 20214486 | 20129910 | 1.7 | 88.7 | null | 2018-09-23 | 2018-10-07 | EOX | 02 | Y | SORAFENIB | 101826337 |
| 20214489 | 20129911 | 1.62 | 80 | Palliative (P) | 2021-04-23 | 2021-04-23 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100045376 |
| 20214494 | 20129912 | null | 100.5 | Neo-adjuvant (N) | 2016-04-07 | 2016-11-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | EOX | 100208802 |
| 20214500 | 20129913 | 1.59 | 65 | null | 2019-07-14 | 2019-07-22 | EOX | N | null | CAPECITABINE + RT | 101260767 |
| 20214501 | 20129914 | 1.84 | 83.1 | Palliative (P) | 2021-08-06 | 2021-08-06 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100078022 |
| 20214502 | 20129915 | 1.64 | 99 | Palliative (P) | 2017-12-14 | 2017-12-14 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100816440 |
| 20214504 | 20129916 | 1.7 | 73 | Palliative (P) | 2020-03-19 | 2020-08-13 | EOX | 02 | N | EOX | 100910177 |
| 20214505 | 20129917 | 1.76 | 95.7 | null | 2019-07-14 | 2019-11-29 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100748869 |
| 20214510 | 20129918 | 1.77 | 92.8 | Neo-adjuvant (N) | 2020-12-20 | 2021-01-01 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | EOX | 100731853 |
| 20214513 | 20129919 | 1.63 | 88.8 | Palliative (P) | 2017-11-30 | 2018-04-15 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100416970 |
| 20214514 | 20129920 | 1.75 | 126.4 | Neo-adjuvant (N) | 2017-02-03 | 2017-02-26 | Sorafenib | 02 | N | SORAFENIB | 101089197 |
| 20214515 | 20129921 | 1.75 | 102 | null | 2017-12-08 | 2017-12-15 | EOX | 2 | null | OXALIPLATIN + RALTITREXED | 101633306 |